Tag: research

SINGAPORE, June 20, 2025 (GLOBE NEWSWIRE) -- Bitcoin has firmly maintained a price above $100,000, signaling that the crypto bull market is still going strong. As market volatility continues, savvy investors are eager to capitalize on the ongoing bullish trend. To help traders make the most of this opportunity, BexBack is launching an exciting promotion that includes a 100% deposit bonus, 100x leverage, and no KYC requirements for crypto futures trading.

– If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors –

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.^3,4 A final decision on the approval in the European Union is expected in the coming months.